Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q4XE
|
|||
| Drug Name |
US9670220, 33
|
|||
| Synonyms |
SCHEMBL322452; BDBM195889; US9670220, 33
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H22FNO4
|
|||
| Canonical SMILES |
C1CN(CC2=C1OC(=C2)C3=CC=C(C=C3)OCC4=CC=CC=C4F)CCC(=O)O
|
|||
| InChI |
1S/C23H22FNO4/c24-20-4-2-1-3-17(20)15-28-19-7-5-16(6-8-19)22-13-18-14-25(12-10-23(26)27)11-9-21(18)29-22/h1-8,13H,9-12,14-15H2,(H,26,27)
|
|||
| InChIKey |
TUHBOROWRALEDS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target's Patent Info | [1] | |
| KEGG Pathway | Sphingolipid signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Pathway Interaction Database | S1P3 pathway | |||
| Sphingosine 1-phosphate (S1P) pathway | ||||
| Reactome | G alpha (i) signalling events | |||
| Lysosphingolipid and LPA receptors | ||||
| WikiPathways | Signal Transduction of S1P Receptor | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fused heterocyclic derivatives as S1P modulators. US9670220. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.